407 related articles for article (PubMed ID: 27025860)
41. [Current approaches for early detection and treatment of medication-related osteonecrosis of jaw].
Janovszky Á; Vereb T; Szabó A; Piffkó J
Orv Hetil; 2014 Dec; 155(49):1960-6. PubMed ID: 25434516
[TBL] [Abstract][Full Text] [Related]
42. Bisphosphonate-related osteonecrosis of the jaws--a review.
Kühl S; Walter C; Acham S; Pfeffer R; Lambrecht JT
Oral Oncol; 2012 Oct; 48(10):938-947. PubMed ID: 22525606
[TBL] [Abstract][Full Text] [Related]
43. Recommendations for the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Systematic Review.
Aparecida Cariolatto F; Carelli J; de Campos Moreira T; Pietrobon R; Rodrigues C; Bonilauri Ferreira AP
J Evid Based Dent Pract; 2018 Jun; 18(2):142-152. PubMed ID: 29747794
[TBL] [Abstract][Full Text] [Related]
44. [Clinical analysis of 24 cases of bisphosphonate-related osteonecrosis of the jaw].
Guo Y; Wang D; An J; Peng X; Cai Z; Guo C
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Sep; 49(9):517-20. PubMed ID: 25476210
[TBL] [Abstract][Full Text] [Related]
45. Dental implications of bisphophonate-related osteonecrosis.
Saldanha S; Shenoy VK; Eachampati P; Uppal N
Gerodontology; 2012 Sep; 29(3):177-87. PubMed ID: 22486711
[TBL] [Abstract][Full Text] [Related]
46. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes.
Lerman MA; Xie W; Treister NS; Richardson PG; Weller EA; Woo SB
Oral Oncol; 2013 Sep; 49(9):977-983. PubMed ID: 23830962
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis.
El-Rabbany M; Sgro A; Lam DK; Shah PS; Azarpazhooh A
J Am Dent Assoc; 2017 Aug; 148(8):584-594.e2. PubMed ID: 28527518
[TBL] [Abstract][Full Text] [Related]
48. Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
Fusco V; Santini D; Armento G; Tonini G; Campisi G
Expert Opin Drug Saf; 2016 Jul; 15(7):925-35. PubMed ID: 27074901
[TBL] [Abstract][Full Text] [Related]
49. Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study.
Martins MA; Martins MD; Lascala CA; Curi MM; Migliorati CA; Tenis CA; Marques MM
Oral Oncol; 2012 Jan; 48(1):79-84. PubMed ID: 21940198
[TBL] [Abstract][Full Text] [Related]
50. Assessing the utility of serum C-telopeptide cross-link of type 1 collagen as a predictor of bisphosphonate-related osteonecrosis of the jaw: A systematic review and meta-analysis.
Enciso R; Keaton J; Saleh N; Ahmadieh A; Clark GT; Sedghizadeh PP
J Am Dent Assoc; 2016 Jul; 147(7):551-560.e11. PubMed ID: 27040417
[TBL] [Abstract][Full Text] [Related]
51. Efficacy of the C-terminal telopeptide test in predicting the development of bisphosphonate-related osteonecrosis of the jaw: a systematic review.
Dal Prá KJ; Lemos CA; Okamoto R; Soubhia AM; Pellizzer EP
Int J Oral Maxillofac Surg; 2017 Feb; 46(2):151-156. PubMed ID: 27876532
[TBL] [Abstract][Full Text] [Related]
52. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
53. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
[TBL] [Abstract][Full Text] [Related]
54. New trends in adjunctive treatment and diagnosis in medication-related osteonecrosis of the jaw: A 10-year review.
De Santis D; Gelpi F; Luciano U; Zarantonello M; Poscolere A; Modena N; Faccioni P; Causarano G; Finotti M; Zotti F; Magi M; Iurlaro A; Nocini PF; Alberti C; Zangani A; Capocasale G; Donadello D; Nocini R; Bernardello F
J Biol Regul Homeost Agents; 2020; 34(6 Suppl. 2):37-48. PubMed ID: 33541063
[TBL] [Abstract][Full Text] [Related]
55. Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin.
Gönen ZB; Yılmaz Asan C
Cranio; 2017 Sep; 35(5):332-336. PubMed ID: 27363584
[TBL] [Abstract][Full Text] [Related]
56. Weak evidence for the management of medication-related osteonecrosis of the jaw: An overview of systematic reviews and meta-analyses.
Moraschini V; Calasans-Maia MD; Louro RS; Arantes EBR; Calasans-Maia JA
J Oral Pathol Med; 2021 Jan; 50(1):10-21. PubMed ID: 32589782
[TBL] [Abstract][Full Text] [Related]
57. Antimicrobial photodynamic and photobiomodulation adjuvant therapies for prevention and treatment of medication-related osteonecrosis of the jaws: Case series and long-term follow-up.
Tartaroti NC; Marques MM; Naclério-Homem MDG; Migliorati CA; Zindel Deboni MC
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101651. PubMed ID: 31923636
[TBL] [Abstract][Full Text] [Related]
58. Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study.
Mauceri R; Panzarella V; Maniscalco L; Bedogni A; Licata ME; Albanese A; Toia F; Cumbo EMG; Mazzola G; Di Fede O; Campisi G
Biomed Res Int; 2018; 2018():3982540. PubMed ID: 30211221
[TBL] [Abstract][Full Text] [Related]
59. Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases.
Altay MA; Tasar F; Tosun E; Kan B
Photomed Laser Surg; 2014 Aug; 32(8):468-75. PubMed ID: 25045921
[TBL] [Abstract][Full Text] [Related]
60. Uncertainty of current algorithm for bisphosphonate-related osteonecrosis of the jaw in population-based studies: a systematic review.
Kim HY; Kim JW; Kim SJ; Lee SH; Lee HS
J Bone Miner Res; 2017 Mar; 32(3):584-591. PubMed ID: 27736017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
